ADMA Biologics, Inc. Announces Annual Meeting of Stockholders on June 4, 2024
Ticker: ADMA · Form: DEF 14A · Filed: Apr 15, 2024 · CIK: 1368514
| Field | Detail |
|---|---|
| Company | Adma Biologics, Inc. (ADMA) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy statement, annual meeting, stockholder vote, virtual meeting, ADMA Biologics
TL;DR
<b>ADMA Biologics will host its virtual Annual Meeting of Stockholders on June 4, 2024, urging shareholders to vote on key proposals.</b>
AI Summary
ADMA BIOLOGICS, INC. (ADMA) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. ADMA Biologics, Inc. will hold its Annual Meeting of Stockholders virtually on June 4, 2024, at 10:00 a.m. Eastern Time. Stockholders can attend and vote via live webcast at www.virtualshareholdermeeting.com/ADMA2024. The proxy statement contains proposals for stockholder consideration and voting. The Board of Directors unanimously recommends a 'FOR' vote on all presented proposals. Stockholders are urged to submit their proxies by Internet, mail, or telephone, or vote at the meeting.
Why It Matters
For investors and stakeholders tracking ADMA BIOLOGICS, INC., this filing contains several important signals. The virtual format ensures all stockholders have a consistent experience regardless of their location. The company emphasizes the importance of stockholder participation through proxy voting to ensure representation at the meeting.
Risk Assessment
Risk Level: low — ADMA BIOLOGICS, INC. shows low risk based on this filing. The filing is a routine proxy statement (DEF 14A) for an annual meeting, containing no new material financial or operational information.
Analyst Insight
Review the proxy statement to understand the proposals and cast your vote by the deadline to ensure your voice is heard.
Key Numbers
- 10:00 a.m. Eastern Time — Meeting Time (Time of the Annual Meeting of Stockholders.)
- June 4, 2024 — Meeting Date (Date of the Annual Meeting of Stockholders.)
- 20240415 — Filing Date (Date the DEF 14A was filed.)
Key Players & Entities
- ADMA BIOLOGICS, INC. (company) — Registrant and filer of the proxy statement.
- June 4, 2024 (date) — Date of the Annual Meeting of Stockholders.
- 20240415 (date) — Filing date of the DEF 14A.
- www.virtualshareholdermeeting.com/ADMA2024 (url) — Link to attend the virtual Annual Meeting.
- R&R ACQUISITION VI, INC (company) — Former company name of ADMA Biologics.
FAQ
When did ADMA BIOLOGICS, INC. file this DEF 14A?
ADMA BIOLOGICS, INC. filed this Proxy Statement (DEF 14A) with the SEC on April 15, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by ADMA BIOLOGICS, INC. (ADMA).
Where can I read the original DEF 14A filing from ADMA BIOLOGICS, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by ADMA BIOLOGICS, INC..
What are the key takeaways from ADMA BIOLOGICS, INC.'s DEF 14A?
ADMA BIOLOGICS, INC. filed this DEF 14A on April 15, 2024. Key takeaways: ADMA Biologics, Inc. will hold its Annual Meeting of Stockholders virtually on June 4, 2024, at 10:00 a.m. Eastern Time.. Stockholders can attend and vote via live webcast at www.virtualshareholdermeeting.com/ADMA2024.. The proxy statement contains proposals for stockholder consideration and voting..
Is ADMA BIOLOGICS, INC. a risky investment based on this filing?
Based on this DEF 14A, ADMA BIOLOGICS, INC. presents a relatively low-risk profile. The filing is a routine proxy statement (DEF 14A) for an annual meeting, containing no new material financial or operational information.
What should investors do after reading ADMA BIOLOGICS, INC.'s DEF 14A?
Review the proxy statement to understand the proposals and cast your vote by the deadline to ensure your voice is heard. The overall sentiment from this filing is neutral.
How does ADMA BIOLOGICS, INC. compare to its industry peers?
ADMA Biologics operates in the biological products sector, focusing on plasma-derived therapeutics.
Are there regulatory concerns for ADMA BIOLOGICS, INC.?
The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
Industry Context
ADMA Biologics operates in the biological products sector, focusing on plasma-derived therapeutics.
Regulatory Implications
The filing is made under Schedule 14A of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
What Investors Should Do
- Review the proxy statement for details on the proposals to be voted on.
- Submit your proxy vote via Internet, mail, or telephone before the meeting.
- Attend the virtual Annual Meeting on June 4, 2024, to participate in the proceedings.
Key Dates
- 2024-06-04: Annual Meeting of Stockholders — Stockholders will vote on proposals presented by the Board of Directors.
- 2024-04-15: Proxy Statement Filing — Definitive Proxy Statement (DEF 14A) filed with the SEC.
Year-Over-Year Comparison
This is a DEF 14A filing for the annual meeting, which is a standard procedural document and does not represent a change from previous filings in terms of new operational or financial data.
Filing Stats: 4,670 words · 19 min read · ~16 pages · Grade level 12.1 · Accepted 2024-04-15 16:31:09
Filing Documents
- ny20023369x1_def14a.htm (DEF 14A) — 673KB
- ny20023369x1_pvp01.jpg (GRAPHIC) — 148KB
- ny20023369x1_pvp02.jpg (GRAPHIC) — 161KB
- sig_adamgrossmanv2.jpg (GRAPHIC) — 8KB
- sig_adamgrossmanv2x1.jpg (GRAPHIC) — 10KB
- ny20023369x1-pc_1.jpg (GRAPHIC) — 491KB
- ny20023369x1-pc_2.jpg (GRAPHIC) — 425KB
- 0001140361-24-019868.txt ( ) — 2383KB
From the Filing
DEF 14A 1 ny20023369x1_def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 90549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant   ☐ Check the appropriate box:   ☐ Preliminary Proxy Statement   ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a–6(e)(2)) ☒ Definitive Proxy Statement   ☐ Definitive Additional Materials   ☐ Soliciting Material under Rule 14a-12 ADMA BIOLOGICS, INC. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required.   ☐ Fee paid previously with preliminary materials.   ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS PROXY STATEMENT DATED APRIL 15, 2024 ADMA BIOLOGICS, INC. 465 State Route 17 Ramsey, New Jersey 07446 Dear Stockholder: You are cordially invited to the annual meeting of stockholders (the “ Annual Meeting ”) of ADMA Biologics, Inc. (the “ Company ”), which will be held virtually at 10:00 a.m. Eastern Time on June 4, 2024. We have adopted a virtual format for our Annual Meeting to provide a consistent experience to all stockholders regardless of location. You will be able to attend the Annual Meeting and vote during the Annual Meeting via live webcast through the link www.virtualshareholdermeeting.com/ADMA2024. In connection with the Annual Meeting, you will be asked to consider and vote on certain proposals that are more fully described in the accompanying proxy statement. Whether or not you plan to attend the Annual Meeting, we urge you to read the proxy statement and consider such information carefully before voting. The Board of Directors unanimously recommends that our stockholders vote “FOR” all of the proposals presented in the proxy statement. Your vote is very important. Even if you plan to attend the Annual Meeting, if you are a stockholder of record of common stock, please submit your proxy by Internet, mail or telephone as soon as possible to make sure that your shares are represented at the Annual Meeting, or you may submit your proxy at the Annual Meeting. If you hold your shares of common stock in “street name” through a bank, broker or other nominee, you must vote in accordance with the voting instructions provided to you by such bank, broker or other nominee, which include instructions for voting by Internet or telephone. On behalf of the Board of Directors, I thank you for your continued support of ADMA Biologics, Inc.   ​ ​ Yours sincerely,   ​ ​     ​ ​ Adam S. Grossman   ​ ​ President, Chief Executive Officer, Interim Chief Financial Officer and Director This proxy statement is dated April 15, 2024. Holders of record of the Company’s common stock at the close of business on April 8, 2024 are entitled to receive notice of, and to vote at, the Annual Meeting. Instructions on how to vote your shares are contained on the “Important Notice Regarding the Availability of Proxy Materials,” which is expected to be mailed on or about April 15, 2024. TABLE OF CONTENTS ADMA BIOLOGICS, INC. 465 State Route 17 Ramsey, New Jersey 07446 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS OF ADMA BIOLOGICS, INC. To Be Held On June 4, 2024 To the Stockholders of ADMA Biologics, Inc. (“ we ,” “ our ” or the “ Company ”): NOTICE IS HEREBY GIVEN that the 2024 annual meeting of stockholders of the Company (the “ Annual Meeting ”) will be held virtually at 10:00 a.m. Eastern Time on June 4, 2024. Virtual Annual Meeting The Company’s Board of Directors (the “ Board ”) has determined to hold a virtual annual meeting in order to facilitate stockholder attendance and participation by enabling stockholders to participate from any location and at no cost. We believe this is the right choice for the Company at this time, as it enables engagement with our stockholders, regardless of size, resources, or physical location. We are committed to ensuring that stockholders will be afforded the same rights and opportunities to participate as they would at an in-person meeting. You will be able to attend the Annual Meeting online and vote your shares electronically during the Annual Meeting by visiting www.virtualshareholdermeeting.com/ADMA2024. To participate in the virtual Annual Me